secwatch.observer — SEC 8-K summary
======================================

Issuer:     Absci Corp (ABSI)
CIK:        0001672688
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001672688-26-000047
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Absci appoints Ransi Somaratne as CMO; Chief Innovation Officer Andreas Busch to retire
--------------------------------------------------------------------------------

- Ransi Somaratne, formerly SVP Clinical Development at Vertex, appointed CMO effective March 3, 2026.
- Andreas Busch, Chief Innovation Officer, will retire March 31, 2026 and serve as scientific advisor for 2 years.
- Busch receives $25,500 annual retainer plus grants of 22,800 stock options and 5,800 RSUs under the 2021 Plan.
- Busch's vested options (2,489,290 shares) extended up to 3 months post-advisory termination; unvested options cancelled.
- Amended director and officer indemnification agreements adopted March 6, 2026, enhancing change-in-control and good faith provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672688/000167268826000047/0001672688-26-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672688/000167268826000047/absc-20260303.htm
  HTML page:      https://secwatch.observer/filing/0001672688-26-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer